Michelle Graham - PAREXEL International President

Ms. Michelle Graham is Senior Vice President, Chief Human Resource Officer of the Company. From January 2015 to July 2016, she served as Corporationrationrate Vice President and Chief Human Resource Officer of the Company. From December 2010 to January 2015, she served as Senior Vice President, Human Resources, at Greatbatch, Inc., a medical device outsource manufacturing company. From 2005 to 2010 she served as Vice President, Human Resources, at Bausch and Lomb Incorporated, a global eye health organization. Prior to this, Ms. Graham worked in human resources for BristolMyers Squibb, a global pharmaceutical company
Age: 48  President Since 2016      
781 487-9900  http://www.parexel.com
Graham holds a Bachelor of Arts in Business Administration and Management and a Master?s of Labor and Industrial Relations from Michigan State University.

Management Efficiency

The company has return on total asset (ROA) of 0.05 % which means that it generated profit of $0.05 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 0.15 % meaning that it created $0.15 on every $100 dollars invested by stockholders.
The company currently holds 671.5 M in liabilities with Debt to Equity (D/E) ratio of 105.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Showing few of many executives


Saumen ChakrabortyDr Reddys Laboratories Ltd
Joseph LaRosaRegeneron Pharmaceuticals
Sripada ChandrasekharDr Reddys Laboratories Ltd
Svend AndersenPerrigo Company Plc
Amit SachdevVertex Pharmaceuticals Incorpor
Samiran DasDr Reddys Laboratories Ltd
Umang VohraDr Reddys Laboratories Ltd
Ronald JanishPerrigo Company Plc
Michael AbermanRegeneron Pharmaceuticals
Clinton LewisZoetis
Ian SmithVertex Pharmaceuticals Incorpor
Louis YuPerrigo Company Plc
Amit BiswasDr Reddys Laboratories Ltd
Paul SilvaVertex Pharmaceuticals Incorpor
K RaoDr Reddys Laboratories Ltd
Kristin PeckZoetis
Alejandro BernalZoetis
Andrew FentonZoetis
Charles MilsteinVertex Pharmaceuticals Incorpor
Raghav ChariDr Reddys Laboratories Ltd
John WesolowskiPerrigo Company Plc

Entity Summary

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people.

PAREXEL International Leadership Team

Michelle Graham, Chief Human Resource Officer, Senior Vice President
Ulf Schneider, Chief Administrative Officer, Senior Vice President
Thomas Senderovitz, Senior Vice President - Clinical Research Services
Dana Callow, Presiding Independent Director
Emma Reeve, Interim CFO, Corporate Vice President Controller
Josef Rickenbach, Founder, Chairman and CEO
Patrick Fortune, Independent Director
Eduard Holdener, Independent Director
Simon Harford, CFO, Senior Vice President
Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access
Gadi Saarony, Senior Vice President - Clinical Research Services
Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center
Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting
Xavier Flinois, President - Perceptive Informatics
Douglas Batt, Sr. VP, General Counsel and Secretary
Sybrand Pretorius, Senior Vice President Chief Scientific Officer
Maykin Ho, Director
Richard Love, Independent Director
Ronald Aldridge, Sr. Director, Investor Relations
Mark Goldberg, President COO
Roland Andersson, Senior Vice President - Clinical Research Services
Christopher Lindop, Independent Director
Ingo Bank, CFO and Sr. VP
David Godwin, Senior Vice President-Global Business

Stock Performance Indicators

Current Sentiment - PRXL

PAREXEL International Investor Sentiment

Most of Macroaxis users are at this time bullish on PAREXEL International Corp. What is your perspective on investing in PAREXEL International Corp? Are you bullish or bearish?
98% Bullish
2% Bearish

Currently Active Assets on Macroaxis

Purchased few shares of
a day ago
Traded for 3.5
Purchased one share of
a day ago
Traded for 6.61
Purchased over 40 shares of
a day ago
Traded for 1.7
Purchased less than 1 share of
a day ago
Traded for 19.84
Purchased one share of
a day ago
Traded for 5.46
See also Your Equity Center. Please also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Search macroaxis.com